Toolkit/synPCB

synPCB

Multi-Component Switch·Research·Since 2020

Also known as: improved synPCB, PCB synthesis system

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

synPCB is a genetically encoded phycocyanobilin synthesis system that supplies the chromophore required for PhyB-PIF phytochrome-based optogenetics. The improved synPCB version increased PCB production by approximately 4-fold and was incorporated with PhyB-PIF into doxycycline-inducible lentiviral and transposon vectors to support light-inducible dimerization system expression or function.

Usefulness & Problems

Why this is useful

synPCB is useful because it enables intracellular production of phycocyanobilin, a required cofactor for PhyB-PIF optogenetic systems. This reduces dependence on exogenous chromophore supply and supports deployment of PhyB-PIF light-inducible dimerization in inducible vector formats.

Source:

resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version

Problem solved

synPCB addresses the need to provide PCB for PhyB-based optogenetics, since the required chromophore is not generally available in typical non-plant, non-cyanobacterial contexts. The improved design specifically addresses insufficient PCB output by increasing synthesis relative to the previous synPCB version.

Published Workflows

Improvement of phycocyanobilin synthesis for genetically encoded phytochrome-based optogenetics

2020

Objective: Improve genetically encoded phycocyanobilin synthesis to support phytochrome-based optogenetics and establish an inducible stable cell line containing the PhyB-PIF system.

Why it works: The workflow combines improved intracellular PCB production with inducible delivery of both the chromophore synthesis module and the PhyB-PIF switch, addressing the chromophore requirement that otherwise limits PhyB use outside organisms that naturally contain these tetrapyrroles.

genetically encoded PCB biosynthesisred/far-red light-inducible PhyB-PIF association and dissociationcomponent replacement with thermophilic cyanobacterial counterpartsfusion-protein engineeringpolycistronic expression designlentiviral and transposon vector incorporation

Stages

  1. 1.
    PCB synthesis module redesign(library_design)

    This stage exists to improve intracellular PCB availability, which is required for PhyB-based optogenetic function.

    Selection: Improve the previously developed synPCB system by changing component origins, protein architecture, and expression design.

  2. 2.
    Functional characterization of improved synPCB(functional_characterization)

    This stage tests whether the redesign improved the intended output of the PCB synthesis system.

    Selection: Measure PCB synthesis relative to the previous synPCB version.

  3. 3.
    Inducible vector-based stable cell line implementation(confirmatory_validation)

    This stage confirms that the improved chromophore synthesis module and the optogenetic switch can be stably and inducibly deployed together in cells.

    Selection: Incorporate PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors to enable doxycycline-inducible system deployment.

Steps

  1. 1.
    Replace PCB synthesis genes with thermophilic cyanobacterial counterpartsengineered PCB synthesis system

    Redesign the synPCB module using alternative source genes for PCB synthesis.

    The abstract presents this as the first engineering change in the improvement campaign.

  2. 2.
    Generate the tFnr-Fd chimeric proteinengineered component within synPCB

    Modify electron transfer-related components by truncating Fnr and fusing it to Fd.

    The abstract explicitly presents this as the second engineering modification after gene replacement.

  3. 3.
    Concatenate PCB synthesis genes with P2A peptide cDNAs for polycistronic expressionengineered PCB synthesis construct

    Enable polycistronic expression of the redesigned PCB synthesis components.

    The abstract presents polycistronic concatenation as the third design change after component replacement and chimera generation.

  4. 4.
    Assess PCB synthesis improvement relative to the previous versionengineered PCB synthesis system under test

    Determine whether the redesigned synPCB increased PCB synthesis.

    This measurement follows the design changes to test whether the intended improvement was achieved before stable deployment.

  5. 5.
    Incorporate synPCB and PhyB-PIF into drug inducible lentiviral and transposon vectorspayload systems and delivery harness

    Prepare inducible delivery formats for stable cellular implementation of chromophore synthesis and the optogenetic switch.

    This follows confirmation of improved PCB synthesis so the optimized module can be deployed together with PhyB-PIF in cells.

  6. 6.
    Induce PCB synthesis and the PhyB-PIF system with doxycyclineinducible deployed system

    Confirm doxycycline-responsive induction of PCB synthesis and the PhyB-PIF LID system in the stable implementation.

    Induction is tested after vector incorporation because doxycycline responsiveness depends on the inducible delivery setup.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.

Target processes

recombination

Input: Light

Implementation Constraints

The system is described as using four PCB synthesis genes, including thermophilic cyanobacterial counterparts, a tFnr-Fd chimera, and P2A-linked polycistronic expression. It was incorporated with PhyB-PIF into doxycycline-inducible lentiviral and transposon vectors to enable inducible PCB synthesis and support PhyB-PIF system expression or function.

The evidence indicates that synPCB supplies chromophore support for PhyB-PIF rather than acting as the light-responsive switch itself. The provided evidence does not report standalone control of a biological process by synPCB, nor does it provide broader validation across multiple cell types, organisms, or application settings.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1inducible controlsupports2020Source 1needs review

Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.

we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Claim 2inducible controlsupports2020Source 1needs review

Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.

we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Claim 3inducible controlsupports2020Source 1needs review

Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.

we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Claim 4inducible expression capabilitysupports2020Source 1needs review

Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.

we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment
Claim 5performance improvementsupports2020Source 1needs review

Concatenating the PCB synthesis genes with P2A peptide cDNAs for polycistronic expression resulted in an approximately 4-fold increase in PCB synthesis compared with the previous version.

these genes were concatenated with P2A peptide cDNAs for polycistronic expression, resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase 4 fold
Claim 6tool improvementsupports2020Source 1needs review

The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.

resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
Claim 7tool improvementsupports2020Source 1needs review

The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.

resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold
Claim 8tool improvementsupports2020Source 1needs review

The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.

resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version
PCB synthesis increase versus previous version approximately 4-fold

Approval Evidence

1 source4 linked approval claimsfirst-pass slug synpcb
Here, we report that we further improved our previously developed PCB synthesis system (synPCB)

Source:

we further improved our previously developed PCB synthesis system (synPCB)

Source:

inducible controlsupports

Drug inducible lentiviral and transposon vectors carrying PhyB-PIF and synPCB enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.

we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment

Source:

inducible expression capabilitysupports

Incorporation of PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors enabled doxycycline-inducible PCB synthesis and PhyB-PIF light-inducible dimerization system expression or function.

we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment

Source:

performance improvementsupports

Concatenating the PCB synthesis genes with P2A peptide cDNAs for polycistronic expression resulted in an approximately 4-fold increase in PCB synthesis compared with the previous version.

these genes were concatenated with P2A peptide cDNAs for polycistronic expression, resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version

Source:

tool improvementsupports

The improved synPCB design increased PCB synthesis by approximately 4-fold compared with the previous version.

resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version

Source:

Comparisons

Source-backed strengths

The improved synPCB design produced an approximately 4-fold increase in PCB synthesis compared with the previous version. Concatenation of the PCB synthesis genes with P2A peptide cDNAs enabled polycistronic expression, and the system was further implemented in doxycycline-inducible lentiviral and transposon vectors together with PhyB-PIF.

Source:

these genes were concatenated with P2A peptide cDNAs for polycistronic expression, resulting in an approximately 4-fold increase in PCB synthesis compared with the previous version

Ranked Citations

  1. 1.
    FoundationalSource 12020Claim 1Claim 2Claim 3

    Derived from 8 linked claims. Example evidence: we incorporated PhyB-PIF and synPCB into drug inducible lentiviral and transposon vectors, which enabled us to induce PCB synthesis and PhyB-PIF LID system by doxycycline treatment